Daniel Tarquinio (Center for Rare Neurological Diseases)

FDA warns pe­di­atric neu­rol­o­gist for fail­ing to check el­i­gi­bil­i­ty of tri­al par­tic­i­pants

The FDA ear­li­er this month sent a warn­ing let­ter to a child neu­rol­o­gist in Geor­gia for en­rolling sub­jects in­to a clin­i­cal study and a sub­se­quent …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.